Shindo J, Ishibashi T, Yokoyama K, Nakazato K, Ohwada T, Shiomi M, Maruyama Y
First Department of Internal Medicine, Fukushima Medical University, Fukushima, Japan.
Circulation. 1999 Apr 27;99(16):2150-6. doi: 10.1161/01.cir.99.16.2150.
A cytokine network is involved in atherogenesis. This study was conducted to investigate the effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) on the development and composition of atherosclerotic lesions in Watanabe heritable hyperlipidemic (WHHL) rabbits.
GM-CSF (10 microg. kg-1. d-1) was administered to 4-month-old WHHL rabbits (n=9) 5 days a week for 7.5 months, whereas an equal dose of human serum albumin was administered to controls (n=9). The cholesterol levels were not changed significantly by the treatment. Age-matched 4-month-old rabbits (n=7) had atheromatous plaques over 30.7+/-5.7% of the inner surface area of the aortic arch. After treatment, the percentages of surface atheromatous plaques to total aortic arch area were 45.0+/-12.6% in the GM-CSF group and 74.3+/-11.0% in controls (P<0.0001). Histological examination demonstrated that GM-CSF reduced the ratio of intima to media (P<0.01) and cross-sectional areas of atherosclerotic lesions (P<0.0001). Quantitative analysis indicated a marked decrease in the areas of smooth muscle cells (P=0.0001), collagen (P=0.0001), and extracellular lipid deposits (P<0.05) of atheromatous plaques in GM-CSF-treated rabbits compared with controls. The terminal deoxynucleotidyltransferase-mediated dUTP-digoxigenin nick end-labeling (TUNEL) method and immunohistochemistry were performed to examine the relationship between decreased atherosclerotic lesions and apoptosis. The percentage of TUNEL-positive cells increased in the GM-CSF group (GM-CSF, 24.1+/-4.4% versus control, 11.6+/-3.2%; P<0.0001). GM-CSF enhanced the apoptosis of smooth muscle cells in the shoulder region and the fibrous cap (P<0.0001), suggesting one of the mechanisms for the antiatherogenic effect.
GM-CSF altered the composition of atherosclerotic lesions and reduced the atherosclerosis in WHHL rabbits.
细胞因子网络参与动脉粥样硬化的发生发展。本研究旨在探讨粒细胞-巨噬细胞集落刺激因子(GM-CSF)对渡边遗传性高脂血症(WHHL)兔动脉粥样硬化病变发展及成分的影响。
对9只4月龄的WHHL兔每周5天给予GM-CSF(10μg·kg-1·d-1),持续7.5个月,而对9只对照组兔给予等量的人血清白蛋白。治疗后胆固醇水平无显著变化。年龄匹配的4月龄兔(7只)主动脉弓内表面有30.7±5.7%的粥样斑块。治疗后,GM-CSF组主动脉弓表面粥样斑块占总面积的百分比为45.0±12.6%,对照组为74.3±11.0%(P<0.0001)。组织学检查显示,GM-CSF降低了内膜与中膜的比例(P<0.01)以及动脉粥样硬化病变的横截面积(P<0.0001)。定量分析表明,与对照组相比,GM-CSF治疗的兔动脉粥样斑块中平滑肌细胞面积(P=0.0001)、胶原蛋白面积(P=0.0001)和细胞外脂质沉积面积(P<0.05)显著减少。采用末端脱氧核苷酸转移酶介导的dUTP-地高辛缺口末端标记(TUNEL)法和免疫组化法检测动脉粥样硬化病变减少与细胞凋亡之间的关系。GM-CSF组TUNEL阳性细胞百分比增加(GM-CSF组为24.1±4.4%,对照组为11.6±3.2%;P<0.0001)。GM-CSF增强了肩部区域和纤维帽处平滑肌细胞的凋亡(P<0.0001),提示这是其抗动脉粥样硬化作用的机制之一。
GM-CSF改变了WHHL兔动脉粥样硬化病变的成分并减轻了动脉粥样硬化。